Abstract: A display device includes a bottom chassis, a flange protruding from an edge of the bottom chassis, a supporting frame disposed along a portion of the edge of the bottom chassis, a double-sided adhesive tape having a first adhesive side and a second adhesive side opposite to the first adhesive side, wherein the first adhesive side is adhered to the supporting frame, a display panel disposed on the bottom chassis and adhered to the second adhesive side of the double-sided adhesive tape, and a light source unit configured to provide light to the display panel. The double-sided adhesive tape is adhered to a first portion of the supporting frame and the double-sided adhesive tape is absent from a second portion of the supporting frame. The second portion of the supporting frame is disposed alongside the flange.

Abstract: The present invention relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a soybean extract comprising coumestrol as an active ingredient, and more specifically relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a germinated and fermented soybean extract comprising coumestrol as an active ingredient.

Abstract: An optical probe for irradiating light onto a subject includes an optical path control unit configured to receive light from outside the optical probe, and change a path of the light within the optical probe; an optical path length control element configured to receive the light having the changed path from the optical path control unit, and change an optical path length of the light as the optical path control unit changes the path of the light; and an optical output unit configured to receive the light having the changed optical path length from the optical path length control element, and output the light.

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

Abstract: A display device includes a bottom chassis, a flange protruding from an edge of the bottom chassis, a supporting frame disposed along a portion of the edge of the bottom chassis, a double-sided adhesive tape having a first adhesive side and a second adhesive side opposite to the first adhesive side, wherein the first adhesive side is adhered to the supporting frame, a display panel disposed on the bottom chassis and adhered to the second adhesive side of the double-sided adhesive tape, and a light source unit configured to provide light to the display panel. The double-sided adhesive tape is adhered to a first portion of the supporting frame and the double-sided adhesive tape is absent from a second portion of the supporting frame. The second portion of the supporting frame is disposed alongside the flange.

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

Abstract: A method of generating a tomographic image includes detecting an interference signal containing cross-sectional information of a target object as raw data of the target object, the raw data being phase-modulated in a first direction with respect to a cross section of the target object; demodulating the raw data by adjusting at least one parameter of a filter function defining filtering using a fixed window size; and generating a tomographic image of the target object by performing signal processing on the demodulated raw data.

Abstract: A method of driving a display panel includes applying gate signals to gate lines of the display panel that extend in a first direction. A plurality of data lines extends in a second direction perpendicular to the first direction. Pixels are defined by an intersection of the gate lines and the data lines. Common electrode contact pixels are provided, in which a common electrode is contacted with a gate electrode extruded from the gate line. A data signal having a first polarity and a data signal having a second polarity, inverse to the first polarity, are applied to an equal number of the common electrode contact pixels.

Abstract: The present invention relates to a dual focusing optical coherence imaging system. The dual focusing optical coherence imaging system includes: a light source unit for generating broadband light; a main optical distributor for distributing the light generated from the light source to allow the light to be propagated; an interference unit including first and second interference parts for forming interference signals with respect to different focused areas of an object to be detected using the light distributed from the optical distributor, and a common sample arm commonly connected to the first and second interference parts; an optical switch connected to the first and second interference parts to select at least one of the interference signals transmitted from the first and second interference parts; and a detection unit for converting the interference signal selected by the optical switch according to a preset mode into an electrical signal.

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

Abstract: A method of driving a display panel includes applying gate signals to gate lines of the display panel that extend in a first direction. A plurality of data lines extends in a second direction perpendicular to the first direction. Pixels are defined by an intersection of the gate lines and the data lines. Common electrode contact pixels are provided, in which a common electrode is contacted with a gate electrode extruded from the gate line. A data signal having a first polarity and a data signal having a second polarity, inverse to the first polarity, are applied to an equal number of the common electrode contact pixels.

Abstract: The present invention relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a soybean extract comprising coumestrol as an active ingredient, and more specifically relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a germinated and fermented soybean extract comprising coumestrol as an active ingredient.

Abstract: The present invention relates to a method for preparing a furofuran lignan compound, comprising a step of selecting and alkylating an epoxy alcohol compound and an optical isomer thereof. (+)-furofuran lignan and (?)-furofuran lignan, as well as an optical isomer thereof, can be selectively prepared by means of the method.

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

Abstract: The present invention relates to a dual focusing optical coherence imaging system. The dual focusing optical coherence imaging system includes: a light source unit for generating broadband light; a main optical distributor for distributing the light generated from the light source to allow the light to be propagated; an interference unit including first and second interference parts for forming interference signals with respect to different focused areas of an object to be detected using the light distributed from the optical distributor, and a common sample arm commonly connected to the first and second interference parts; an optical switch connected to the first and second interference parts to select at least one of the interference signals transmitted from the first and second interference parts; and a detection unit for converting the interference signal selected by the optical switch according to a preset mode into an electrical signal.

Abstract: A method of generating a tomographic image includes detecting an interference signal containing cross-sectional information of a target object as raw data of the target object, the raw data being phase-modulated in a first direction with respect to a cross section of the target object; demodulating the raw data by adjusting at least one parameter of a filter function defining filtering using a fixed window size; and generating a tomographic image of the target object by performing signal processing on the demodulated raw data.

Abstract: The present invention relates to a composition for activating mitochondria comprising coumestrol or a bean extract containing coumestrol.